Suzanne D. Vernon , PhD, is the Research Liaison at Bateman Horne Center of Excellence which specializes in treatment and research for ME/CFS and Fibromyalgia and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of microbiome samples for research and development.
From November 2007 to May 2015, Dr. Vernon was the Scientific Director of Solve ME/CFS Initiative, formerly known as CFIDS Association of America. While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/ CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/ CFS. The core of RIWW is the SolveCFS BioBank & Patient Registry.
From May 1990 to October 2007, Dr. Vernon worked for the US Centers for Disease Control , first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under William Reeves , MD, the Director of the CDC Chronic Fatigue Research Program.
In 2005, Dr Vernon was one of the authors of the CDC case definition of CFS , commonly called the Reeves criteria .
Full BioLearn about our editorial policies
Despite a decade of research into the origins of chronic fatigue syndrome (CFS), researchers still don't know what causes this debilitating disorder. And there are no known steps you can take to prevent it. However, research continues into the possible causes and treatment of CFS.
